92 related articles for article (PubMed ID: 3527953)
1. Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).
Burmeister G; Tarcsay L; Sorg C
Immunobiology; 1986 Jul; 171(4-5):461-74. PubMed ID: 3527953
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
Fahlbusch B; Metzner G; Schumann I; Tittel R
Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
Fahlbusch B; Schumann I
Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
[TBL] [Abstract][Full Text] [Related]
4. Murine monoclonal antibodies directed against human recombinant Macrophage Migration Inhibitory Factor.
Rupreht RR; Moyetic B; Franckz A; Matis M; Skoberne M; Galvani V; Malovrh T; Kotnik V; Curin Serbec V
Pflugers Arch; 2000; 440(5 Suppl):R78-80. PubMed ID: 11005620
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody against migration inhibitory factor (MIF) obtained by immunization with MIF from the human lymphoblast cell line Mo.
Kawaguchi T; Mednis A; Golde DW; David JR; Remold HR
J Leukoc Biol; 1986 Feb; 39(2):223-32. PubMed ID: 3079811
[TBL] [Abstract][Full Text] [Related]
6. Studies on human migration inhibitory factor: characterization of three molecular species.
Weiser WY; Greineder DK; Remold HG; David JR
J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
[TBL] [Abstract][Full Text] [Related]
7. Human migration inhibitory factor: purification and immunochemical characterization.
Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
J Exp Med; 1978 Feb; 147(2):541-53. PubMed ID: 75241
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor has a MHC class I-like motif and function.
Gibbings DJ; Ghetu AF; Dery R; Befus AD
Scand J Immunol; 2008 Feb; 67(2):121-32. PubMed ID: 18201367
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and biologic activity study of (125);I-labeled anti-MIF monoclonal antibody].
Song J; Zhang C; Liang T; Xu J; Hou GH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1223-5. PubMed ID: 21138688
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
Sorg C; Geczy CL
Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
[TBL] [Abstract][Full Text] [Related]
11. Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.
Zhang Y; Zeng X; Chen S; Zhang Z; Li P; Yi W; Huang H; Yao J; Li S; Hu C
Int Immunopharmacol; 2011 Sep; 11(9):1333-40. PubMed ID: 21571101
[TBL] [Abstract][Full Text] [Related]
12. Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF.
Weiser WY; Remold HG; David JR
Cell Immunol; 1985 Jan; 90(1):167-78. PubMed ID: 3881187
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Li S; Zhang R; Li P; Yi W; Zhang Z; Chen S; Su S; Zhao L; Hu C
Int Immunopharmacol; 2008 Jun; 8(6):859-65. PubMed ID: 18442790
[TBL] [Abstract][Full Text] [Related]
14. Studies on guinea-pig macrophage migration inhibitory factor (MIF). II. Purification of MIF after treatment with reducing and denaturing agents.
Kotkes P; Pick E
Clin Exp Immunol; 1979 Sep; 37(3):540-50. PubMed ID: 389497
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor.
Liu DY; Todd RF
J Immunol; 1986 Jul; 137(2):448-55. PubMed ID: 3522731
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
Oki S; Hirose S; Higuchi M; Osawa T
Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
[TBL] [Abstract][Full Text] [Related]
17. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
Remold HG; Mednis AD
J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
Fahlbusch B; Tittel R
Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
[TBL] [Abstract][Full Text] [Related]
19. Identification of a human monocyte antigen (Mo3e) associated with cellular activation and lymphokine responsiveness.
Liu DY; Ree JY; Trochelman RD; Todd RF
Eur J Immunol; 1989 Apr; 19(4):721-7. PubMed ID: 2659370
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization of murine migration inhibitory factor (MIF).
Kühner AL; David JR
J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
